Lv2
150 积分 2025-07-07 加入
Discovery of BI-2493, a Pan-KRAS Inhibitor Showing In Vivo Efficacy
29天前
已完结
Analysis of Pan-Specific Inhibitors of Oncogenic Mutant Forms of KRAS GTPase
29天前
已完结
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
29天前
已完结
GD2-directed NAMPT inhibition using antibody-drug conjugates in neuroblastoma
1个月前
已完结
GD2-directed NAMPT inhibition using antibody-drug conjugates in neuroblastoma
1个月前
已完结
Novel Linkers and Connections for antibody–drug Conjugates to Treat Cancer and Infectious Disease
4个月前
已关闭
Novel Linkers and Connections for antibody–drug Conjugates to Treat Cancer and Infectious Disease
4个月前
已关闭
Novel Linkers and Connections for antibody–drug Conjugates to Treat Cancer and Infectious Disease
4个月前
已关闭
A Study of MEDI1191 Alone and in Combination With Durvalumab in Subjects With Advanced Solid Tumors
4个月前
已关闭
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination Strategies
4个月前
已完结
皖公网安备34019202002308
